These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8347330)

  • 21. Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease.
    Xuereb JH; Perry EK; Candy JM; Bonham JR; Perry RH; Marshall E
    J Neurol Sci; 1990 Nov; 99(2-3):185-97. PubMed ID: 1964958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of morphological changes in Parkinson's disease.
    Jellinger K
    Adv Neurol; 1987; 45():1-18. PubMed ID: 3825687
    [No Abstract]   [Full Text] [Related]  

  • 23. Cholinergic dysfunction in diseases with Lewy bodies.
    Tiraboschi P; Hansen LA; Alford M; Sabbagh MN; Schoos B; Masliah E; Thal LJ; Corey-Bloom J
    Neurology; 2000 Jan; 54(2):407-11. PubMed ID: 10668703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
    J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
    Perry EK; Smith CJ; Court JA; Perry RH
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy.
    Brandel JP; Hirsch EC; Malessa S; Duyckaerts C; Cervera P; Agid Y
    Neuroscience; 1991; 41(1):25-31. PubMed ID: 2057062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calbindin D-28k and monoamine oxidase A immunoreactive neurons in the nucleus basalis of Meynert in senile dementia of the Alzheimer type and Parkinson's disease.
    Chan-Palay V; Höchli M; Savaskan E; Hungerecker G
    Dementia; 1993; 4(1):1-15. PubMed ID: 8358501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
    Candy JM; Perry EK; Perry RH; Court JA; Oakley AE; Edwardson JA
    Prog Brain Res; 1986; 70():105-32. PubMed ID: 3554348
    [No Abstract]   [Full Text] [Related]  

  • 29. Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease.
    Kerwin JM; Morris CM; Perry RH; Perry EK
    Neurosci Lett; 1992 Aug; 143(1-2):101-4. PubMed ID: 1436650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dementia with cerebral Lewy bodies. A mesocortical dopaminergic defect?
    Eggertson DE; Sima AA
    Arch Neurol; 1986 May; 43(5):524-7. PubMed ID: 3964123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The locus ceruleus and dementia in Parkinson's disease.
    Zweig RM; Cardillo JE; Cohen M; Giere S; Hedreen JC
    Neurology; 1993 May; 43(5):986-91. PubMed ID: 8492957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nucleus basalis of Meynert in neurological dementing disease: a review.
    Chozick B
    Int J Neurosci; 1987 Nov; 37(1-2):31-48. PubMed ID: 2960633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Lewy body disease': clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia.
    de Vos RA; Jansen EN; Stam FC; Ravid R; Swaab DF
    Clin Neurol Neurosurg; 1995 Feb; 97(1):13-22. PubMed ID: 7788967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients.
    Kordower JH; Gash DM; Bothwell M; Hersh L; Mufson EJ
    Neurobiol Aging; 1989; 10(1):67-74. PubMed ID: 2547171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pathological study of the association between Lewy body disease and Alzheimer's disease.
    Gibb WR; Mountjoy CQ; Mann DM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jun; 52(6):701-8. PubMed ID: 2545826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of the nucleus basalis of Meynert in dementia: review and reconsideration.
    Cummings JL; Benson DF
    Alzheimer Dis Assoc Disord; 1987; 1(3):128-55. PubMed ID: 3331115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain.
    Perry EK; Lee ML; Martin-Ruiz CM; Court JA; Volsen SG; Merrit J; Folly E; Iversen PE; Bauman ML; Perry RH; Wenk GL
    Am J Psychiatry; 2001 Jul; 158(7):1058-66. PubMed ID: 11431227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease.
    Rinne JO; Lönnberg P; Marjamäki P; Rinne UK
    Brain Res; 1989 Apr; 483(2):402-6. PubMed ID: 2706531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein.
    Harrington CR; Perry RH; Perry EK; Hurt J; McKeith IG; Roth M; Wischik CM
    Dementia; 1994; 5(5):215-28. PubMed ID: 7951676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.